1. Home
  2. QNCX vs ASRT Comparison

QNCX vs ASRT Comparison

Compare QNCX & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QNCX
  • ASRT
  • Stock Information
  • Founded
  • QNCX 2012
  • ASRT 1995
  • Country
  • QNCX United States
  • ASRT United States
  • Employees
  • QNCX N/A
  • ASRT N/A
  • Industry
  • QNCX Biotechnology: Biological Products (No Diagnostic Substances)
  • ASRT Biotechnology: Pharmaceutical Preparations
  • Sector
  • QNCX Health Care
  • ASRT Health Care
  • Exchange
  • QNCX Nasdaq
  • ASRT Nasdaq
  • Market Cap
  • QNCX 62.0M
  • ASRT 78.3M
  • IPO Year
  • QNCX 2019
  • ASRT 1997
  • Fundamental
  • Price
  • QNCX $1.42
  • ASRT $0.86
  • Analyst Decision
  • QNCX Strong Buy
  • ASRT Strong Buy
  • Analyst Count
  • QNCX 4
  • ASRT 4
  • Target Price
  • QNCX $9.50
  • ASRT $3.19
  • AVG Volume (30 Days)
  • QNCX 124.3K
  • ASRT 327.3K
  • Earning Date
  • QNCX 03-31-2025
  • ASRT 03-10-2025
  • Dividend Yield
  • QNCX N/A
  • ASRT N/A
  • EPS Growth
  • QNCX N/A
  • ASRT N/A
  • EPS
  • QNCX N/A
  • ASRT N/A
  • Revenue
  • QNCX N/A
  • ASRT $125,763,000.00
  • Revenue This Year
  • QNCX N/A
  • ASRT N/A
  • Revenue Next Year
  • QNCX N/A
  • ASRT $1.84
  • P/E Ratio
  • QNCX N/A
  • ASRT N/A
  • Revenue Growth
  • QNCX N/A
  • ASRT N/A
  • 52 Week Low
  • QNCX $0.51
  • ASRT $0.73
  • 52 Week High
  • QNCX $2.45
  • ASRT $1.80
  • Technical
  • Relative Strength Index (RSI)
  • QNCX 37.52
  • ASRT 53.75
  • Support Level
  • QNCX $1.37
  • ASRT $0.78
  • Resistance Level
  • QNCX $1.69
  • ASRT $0.88
  • Average True Range (ATR)
  • QNCX 0.12
  • ASRT 0.03
  • MACD
  • QNCX -0.02
  • ASRT 0.01
  • Stochastic Oscillator
  • QNCX 12.20
  • ASRT 75.00

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing innovative precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics.

About ASRT Assertio Holdings Inc.

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

Share on Social Networks: